Crossmark

Proprotein convertase subtilisin/kexin type 9 inhibitors in secondary prevention of vascular events in patients with stroke: Consensus document and practice guidance

Crossref DOI link: https://doi.org/10.1016/j.nrleng.2020.11.014

Published Print: 2022-03

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Gil-Núñez, A.

Masjuan, J.

Montaner, J.

Castellanos, M.

Segura, T.

Cardona, P.

Tembl, J.I.

Purroy, F.

Arenillas, J.

Palacio, E.
License Information

Text and Data Mining valid from 2022-03-01

Version of Record valid from 2021-12-03
More Information

This article is maintained by: Elsevier

Article Title: Proprotein convertase subtilisin/kexin type 9 inhibitors in secondary prevention of vascular events in patients with stroke: Consensus document and practice guidance

Journal Title: Neurología (English Edition)

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.nrleng.2020.11.014

CrossRef DOI link to the associated document: https://doi.org/10.1016/j.nrl.2020.11.006

Content Type: simple-article

Copyright: © 2020 Sociedad Española de Neurología. Published by Elsevier España, S.L.U.

Document is current

Any future updates will be listed below